Arcutis Biotherapeutics, Inc. (ARQT) Financials
ARQT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 341.4 million | 252.7 million |
2023-09-30 | 293.0 million | 246.2 million |
2023-06-30 | 320.7 million | 240.2 million |
2023-03-31 | 379.5 million | 239.7 million |
ARQT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -56.3 million | 8.8 million |
2023-09-30 | -44.0 million | 10.0 million |
2023-06-30 | -66.8 million | 10.6 million |
2023-03-31 | -80.4 million | 9.5 million |
ARQT Net Income
No data available :(
ARQT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 272.8 million | - | 4.1 million |
2023-09-30 | 227.1 million | - | 4.3 million |
2023-06-30 | 268.7 million | 199.8 million | 4.5 million |
2023-03-31 | 332.4 million | 198.8 million | 4.6 million |
ARQT Shares Outstanding
ARQT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 6000 | 23.8 million | 48.7 million | - |
2023-09-30 | 64000 | 26.2 million | 47.6 million | - |
2023-06-30 | 276000 | 25.2 million | 46.0 million | - |
2023-03-31 | 82000 | 35.3 million | 5.8 million | 37.1 million |
ARQT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 13.5 million | 2.4 million |
2023-09-30 | 38.1 million | 1.2 million |
2023-06-30 | 5.2 million | 776000 |
2023-03-31 | 2.8 million | 783000 |
ARQT
Price: $8.47
52 week price:
Earnings Per Share: -3.78 USD
P/E Ratio: -1.40
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 827862
Market Capitalization: 1.3 billion